Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
33%
upside
5 price targets
|
0
%
|
|
|
|
33%
upside
4 price targets
|
0
%
|
|
|
|
33%
upside
5 price targets
|
0
%
|
|
|
154
Adaptive Biotechnologies
ADPT
$2.38B
|
33%
upside
5 price targets
|
0
%
|
|
|
32%
upside
5 price targets
|
0
%
|
|
|
|
32%
upside
15 price targets
|
0
%
|
|
|
|
32%
upside
6 price targets
|
0
%
|
|
|
|
32%
upside
7 price targets
|
0
%
|
|
|
|
32%
upside
8 price targets
|
0
%
|
|
|
|
32%
upside
4 price targets
|
0
%
|
|
|
161
Baxter International
BAX
$9.24B
|
32%
upside
4 price targets
|
0
%
|
|
|
32%
upside
7 price targets
|
0
%
|
|
|
|
32%
upside
5 price targets
|
0
%
|
|
|
|
31%
upside
3 price targets
|
0
%
|
|
|
|
31%
upside
5 price targets
|
0
%
|
|
|
|
31%
upside
5 price targets
|
0
%
|
|
|
|
31%
upside
4 price targets
|
0
%
|
|
|
|
31%
upside
4 price targets
|
0
%
|
|
|
|
31%
upside
14 price targets
|
0
%
|
|
|
|
31%
upside
4 price targets
|
0
%
|
|
|
|
31%
upside
10 price targets
|
0
%
|
|
|
|
31%
upside
3 price targets
|
0
%
|
|
|
|
31%
upside
5 price targets
|
0
%
|
|
|
|
30%
upside
3 price targets
|
0
%
|
|
|
|
30%
upside
4 price targets
|
0
%
|
|